The National Institutes of Health has resumed terminating grant funding for research on health disparities, a year after a federal judge ruled that an earlier round of mass cancellations was illegal.
The agency has formally ended at least one grant, with more cancellations expected, according to NIH staffers and internal documents reviewed by the journal Science. Science confirmed one termination, of a grant awarded by the National Institute of Mental Health in December 2024 for five years of research at Emory University on changes in brain activity caused by racial discrimination.
Disparities research is a broader category than the label suggests. It covers why rural patients die at higher rates from treatable conditions, why maternal mortality varies sharply by geography and income, and why cancer survival differs between patients with the same diagnosis at different hospitals.
Research Categories Affected by the Terminations
The work grouped under this heading is largely practical rather than theoretical. It asks why two patients with identical diagnoses experience different outcomes, and it is the mechanism by which health systems learn what to fix.
Rural access research examines what happens when a hospital closes and the nearest obstetric unit becomes 90 minutes away. Maternal mortality research tracks preventable deaths and near-misses. Cancer survival research examines why a patient treated far from a specialized center does worse than one nearby. An American Association for Cancer Research report found rural Americans are 18 percent more likely to die from cancer overall, and Black women 35 percent more likely to die from breast cancer than white women.
The people who lose most when this work stops are not defined by any single demographic category. They are patients in rural counties, people on Medicaid, patients at safety-net hospitals, and anyone whose care happens outside a major academic medical center.
Robert Winn, cancer center director at Fox Chase Cancer Center, put the consequence directly, saying that "If we take our foot off the pedal of disparities research," more Americans in rural communities and away from centers of excellence will not do well. In the same survey reported by NPR, 93 percent of cancer researchers studying disparities said federal policy changes had affected their work.
Legal Backdrop After Last Year's Court Ruling
The current terminations follow a much larger earlier round. More than 2,300 NIH grants were terminated by late June 2025, and nearly 1,100 grants remained terminated this spring, according to KFF's tracking. Judge William G. Young of the United States District Court for the District of Massachusetts subsequently ruled the terminations unlawful, calling them arbitrary and capricious and saying from the bench that he had never seen "government racial discrimination like this." The court then ordered hundreds of grants restored, and many were.
Science reports the agency now appears to be using a process it hopes will prove more legally defensible than those hasty cancellations, though the new terminations may run afoul of a more recent court ruling.
Unlike last year, the agency has stated reasoning for at least this cancellation. The termination notice says the research does not align with an NIH priority to study scientifically valid, measurable health outcomes, describes the project's method of measuring racial discrimination as subjective because different people could interpret the same experience differently, and argues that studying only Black participants limits comparisons and controls. Researchers in the field dispute that characterization, noting the evidence base linking discrimination to health outcomes is well established.
Internal documents also indicate a shift in how these grants are handled. NIH staff had often worked with principal investigators to adjust projects so they no longer conflicted with agency priorities. According to notes viewed by Science, staff were told in April they could not renegotiate one grant, and a May note instructed them not to align it to agency priorities. Additional documents indicate at least one more disparities grant is poised to end without renegotiation.
Slowdown Beyond Formal Cancellations
Terminations are the visible part. Researchers describe a broader funding contraction that does not appear in any cancellation list.
Fewer new grants have been awarded this year by the National Cancer Institute and the National Institute on Minority Health and Health Disparities than at the same point in previous years, and researchers report a continued slowdown in grant making and renewals. In the 2025 round, the mental health and minority health institutes lost the most grants of any NIH components, 128 and 77, respectively.
That distinction matters for anyone assessing the scale. A terminated grant can be litigated and sometimes restored. A grant application that is never funded, or a renewal that stalls, leaves no paper trail and no plaintiff.
The practical effect on research is cumulative. Multi-year studies depend on continuous funding to retain staff and follow participants over time. An interruption of even months can end a cohort study permanently, because participants disperse and trained personnel move on. Restoring the money later does not restore the data.
Patient Groups Most Exposed to the Gap
This story has no immediate action item for an individual household, and it would be dishonest to invent one. Nobody's appointment changes next week because a grant ended.
The exposure is slower and geographic. Patients in rural counties with fewer specialists, people delivering babies in areas that have lost obstetric services, and patients receiving cancer care outside academic centers depend on this research being done by someone. When it is not, the questions simply go unanswered, and practice changes that would have followed do not happen.
People who want to follow this can track NIH RePORTER, the agency's public grant database, and the outcomes of ongoing litigation over the earlier terminations. Researchers affected by a termination generally have administrative appeal options through their institution's sponsored programs office.
What happens next depends on whether the courts treat the new termination process differently from the old one, and whether additional grants are ended in the coming weeks. MedicalDaily will report confirmed terminations and any rulings.
The bottom line: the newest confirmed development is that NIH has resumed terminating health disparities grants using a revised process with stated scientific reasoning, the patients most exposed are those in rural and safety-net settings whose outcome gaps this research examines, and the legal status of the new terminations remains unresolved.
Frequently Asked Questions
What has NIH done? The agency has resumed terminating grant funding for health disparities research, formally ending at least one and preparing additional cancellations, according to internal documents reviewed by Science.
Which grant was confirmed as terminated? A National Institute of Mental Health grant awarded in December 2024 for five years of research at Emory University on changes in brain activity caused by racial discrimination.
What is health disparities research? Research examining why patients with similar conditions have different outcomes, covering areas including rural access to care, maternal mortality, and differences in cancer survival.
Did courts previously block these terminations? Yes. A federal judge found the earlier mass termination of more than 1,700 grants illegal and arbitrary, and many were restored. Science reports the agency is now using a process it hopes will be more legally defensible.
Has NIH explained why? For this grant, yes. The notice cites a lack of alignment with an NIH priority on measurable health outcomes, calls the discrimination measure subjective, and questions studying only Black participants. Researchers in the field dispute that reasoning.
Are new grants still being awarded? Fewer new awards have been made this year by the National Cancer Institute and the National Institute on Minority Health and Health Disparities than at the same point in prior years.
Does this change patient care right now? Not directly or immediately. The effect is cumulative, falling hardest over time on patients in rural areas, safety-net hospitals and communities far from specialized centers.
